secukinumab,adalimumab
novartis,abbvie
['adalimumab', 'secukinumab', 'spondylitis', 'surpass', ' hs ']
head to head trial comparing secukinumab and adalimumab biosimilar in axial-spa ( structural progression ). no difference! thats assuring. #eular2023 
Rheumatologist and life long learner 🤓. Citizen of the world.Special shoutout to my students and patients, you got this💪🏽. 😷